Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

NCT00674258 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: URLC10, TTK and KOC1

Sponsor

Tokyo University

Collaborators

[object Object]